n-(3-pyridylmethyl)adriamycin has been researched along with Black Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charan Raja, MR; Harish, BS; Jayaraman, A; Kar Mahapatra, S; Kar, A; Srinivasan, S; Uppuluri, KB | 1 |
1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and Black Fever
| Article | Year |
|---|---|
Oceanimonas sp. BPMS22-derived protein protease inhibitor induces anti-leishmanial immune responses through macrophage M2 to M1 repolarization.
Topics: Animals; Arginase; Cytokines; Immunity; Interleukin-12; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Nitric Oxide; Protease Inhibitors; RNA, Messenger; Serine; Tandem Mass Spectrometry; Trypsin | 2022 |